Resveratrol inhibits high glucose induced collagen upregulation in cardiac fibroblasts through regulating TGF-β1-Smad3 signaling pathway

Chemico-Biological Interactions

Volumn 227, Issue , 2015, Pages 45-52

  Liu, Junhui ^a   Zhuo, Xiaozhen ^a   Liu, Weimin ^a   Wan, Zhaofei ^a   Liang, Xiao ^a   Gao, Shanshan ^a   Yuan, Zuyi ^a   Wu, Yue ^a  

^a THE FIRST AFFILIATED HOSPITAL OF XI AN JIAOTONG UNIVERSITY   (China)

Author keywords

Angiotensin II (Ang II); Cardiac fibroblasts (CFs); Cardiac fibrosis; Collagens; Resveratrol (Res)

Indexed keywords

ANGIOTENSIN II; COLLAGEN; GLUCOSE; RESVERATROL; SMAD3 PROTEIN; TRANSFORMING GROWTH FACTOR BETA1; STILBENE DERIVATIVE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARDIAC FIBROBLAST; CELL PROLIFERATION; COLLAGEN METABOLISM; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; ENZYME LINKED IMMUNOSORBENT ASSAY; FIBROBLAST; HEART MUSCLE FIBROSIS; IN VIVO STUDY; MALE; MOUSE; NONHUMAN; PROTEIN EXPRESSION; RAT; REAL TIME POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; UPREGULATION; ANIMAL; C57BL MOUSE; CELL CULTURE; CHEMICALLY INDUCED; CYTOLOGY; DRUG EFFECTS; EXPERIMENTAL DIABETES MELLITUS; HEART MUSCLE; METABOLISM; PATHOLOGY; WISTAR RAT;

MUS; RATTUS;

ANGIOTENSIN II; ANIMALS; CELL PROLIFERATION; CELLS, CULTURED; COLLAGEN; DIABETES MELLITUS, EXPERIMENTAL; FIBROBLASTS; GLUCOSE; MICE; MICE, INBRED C57BL; MYOCARDIUM; RATS; RATS, WISTAR; SIGNAL TRANSDUCTION; SMAD3 PROTEIN; STILBENES; TRANSFORMING GROWTH FACTOR BETA1; UP-REGULATION;

EID: 84920647836     PISSN: 00092797     EISSN: 18727786     Source Type: Journal    
DOI: 10.1016/j.cbi.2014.12.031     Document Type: Article

References (39)

1. P.E. Shamhart, D.J. Luther, B.R. Hodson, J.C. Koshy, V. Ohanyan, and J.G. Meszaros Impact of type 1 diabetes on cardiac fibroblast activation: enhanced cell cycle progression and reduced myofibroblast content in diabetic myocardium Am. J. Physiol. Endocrinol. Metab. 297 2009 E1147 E1153
2. R. Eschalier, P. Rossignol, A. Kearney-Schwartz, C. Adamopoulos, K. Karatzidou, R. Fay, D. Mandry, P.Y. Marie, and F. Zannad Features of cardiac remodeling, associated with blood pressure and fibrosis biomarkers, are frequent in subjects with abdominal obesity Hypertension 63 2014 740 746
3. P. Kong, P. Christia, and N.G. Frangogiannis The pathogenesis of cardiac fibrosis Cell. Mol. Life Sci. 71 2014 549 574
4. L. van Heerebeek, N. Hamdani, M.L. Handoko, I. Falcao-Pires, R.J. Musters, K. Kupreishvili, A.J. Ijsselmuiden, C.G. Schalkwijk, J.G. Bronzwaer, M. Diamant, A. Borbely, J. van der Velden, G.J. Stienen, G.J. Laarman, H.W. Niessen, and W.J. Paulus Diastolic stiffness of the failing diabetic heart: importance of fibrosis, advanced glycation end products, and myocyte resting tension Circulation 117 2008 43 51
5. G. Krenning, E.M. Zeisberg, and R. Kalluri The origin of fibroblasts and mechanism of cardiac fibrosis J. Cell. Physiol. 225 2010 631 637
6. A. Bugyei-Twum, A. Advani, S.L. Advani, Y. Zhang, K. Thai, D.J. Kelly, and K.A. Connelly High glucose induces Smad activation via the transcriptional coregulator p300 and contributes to cardiac fibrosis and hypertrophy Cardiovasc. Diabetol. 13 2014 89
7. M. Tang, W. Zhang, H. Lin, H. Jiang, H. Dai, and Y. Zhang High glucose promotes the production of collagen types I and III by cardiac fibroblasts through a pathway dependent on extracellular-signal-regulated kinase 1/2 Mol. Cell. Biochem. 301 2007 109 114
8. L.N. Wang, C. Wang, Y. Lin, Y.H. Xi, W.H. Zhang, Y.J. Zhao, H.Z. Li, Y. Tian, Y.J. Lv, B.F. Yang, and C.Q. Xu Involvement of calcium-sensing receptor in cardiac hypertrophy-induced by angiotensin II through calcineurin pathway in cultured neonatal rat cardiomyocytes Biochem. Biophys. Res. Commun. 369 2008 584 589
9. S. Johar, A.C. Cave, A. Narayanapanicker, D.J. Grieve, and A.M. Shah Aldosterone mediates angiotensin II-induced interstitial cardiac fibrosis via a Nox2-containing NADPH oxidase FASEB J. 20 2006 1546 1548
10. A. Leask TGFbeta, cardiac fibroblasts, and the fibrotic response Cardiovasc. Res. 74 2007 207 212
11. H. Xiao, X. Ma, W. Feng, Y. Fu, Z. Lu, M. Xu, Q. Shen, Y. Zhu, and Y. Zhang Metformin attenuates cardiac fibrosis by inhibiting the TGFbeta1-Smad3 signalling pathway Cardiovasc. Res. 87 2010 504 513
12. A.A. Lee, W.H. Dillmann, A.D. McCulloch, and F.J. Villarreal Angiotensin II stimulates the autocrine production of transforming growth factor-beta 1 in adult rat cardiac fibroblasts J. Mol. Cell. Cardiol. 27 1995 2347 2357
13. B. Kpl, J.W. Kosmeder 2nd, and J.M. Pezzuto Biological effects of resveratrol Antioxid. Redox Signal. 3 2001 1041 1064
14. C.H. Cottart, V. Nivet-Antoine, and J.L. Beaudeux Review of recent data on the metabolism, biological effects, and toxicity of resveratrol in humans Mol. Nutr. Food Res. 58 2014 7 21
15. E. Chavez, K. Reyes-Gordillo, J. Segovia, M. Shibayama, V. Tsutsumi, P. Vergara, M.G. Moreno, and P. Muriel Resveratrol prevents fibrosis, NF-kappaB activation and TGF-beta increases induced by chronic CCl4 treatment in rats J. Appl. Toxicol. 28 2008 35 43
16. S.W. Hong, K.H. Jung, H.M. Zheng, H.S. Lee, J.K. Suh, I.S. Park, D.H. Lee, and S.S. Hong The protective effect of resveratrol on dimethylnitrosamine-induced liver fibrosis in rats Arch. Pharm. Res. 33 2010 601 609
17. R. Akgedik, S. Akgedik, H. Karamanli, S. Uysal, B. Bozkurt, D. Ozol, F. Armutcu, and Z. Yildirim Effect of resveratrol on treatment of bleomycin-induced pulmonary fibrosis in rats Inflammation 35 2012 1732 1741
18. F. Ma, Y. Li, L. Jia, Y. Han, J. Cheng, H. Li, Y. Qi, and J. Du Macrophage-stimulated cardiac fibroblast production of IL-6 is essential for TGF beta/Smad activation and cardiac fibrosis induced by angiotensin II PLoS One 7 2012 e35144
19. T.D. Schmittgen, and K.J. Livak Analyzing real-time PCR data by the comparative C(T) method Nat. Protoc. 3 2008 1101 1108
20. P.J. Lijnen, V.V. Petrov, and R.H. Fagard Induction of cardiac fibrosis by angiotensin II Methods Find. Exp. Clin. Pharmacol. 22 2000 709 723
21. R. Khan, and R. Sheppard Fibrosis in heart disease: understanding the role of transforming growth factor-beta in cardiomyopathy, valvular disease and arrhythmia Immunology 118 2006 10 24
22. M. Pauschinger, D. Knopf, S. Petschauer, A. Doerner, W. Poller, P.L. Schwimmbeck, U. Kuhl, and H.P. Schultheiss Dilated cardiomyopathy is associated with significant changes in collagen type I/III ratio Circulation 99 1999 2750 2756
23. S. Bradamante, L. Barenghi, and A. Villa Cardiovascular protective effects of resveratrol Cardiovasc. Drug Rev. 22 2004 169 188
24. L.G. Bukarica, D. Protic, V. Kanjuh, H. Heinle, R. Novakovic, and R. Scepanovic Cardiovascular effects of resveratrol Vojnosanit. Pregl. 70 2013 1145 1150
25. A. Prasad, and A.A. Quyyumi Renin-angiotensin system and angiotensin receptor blockers in the metabolic syndrome Circulation 110 2004 1507 1512
26. K. Fujita, N. Maeda, M. Sonoda, K. Ohashi, T. Hibuse, H. Nishizawa, M. Nishida, A. Hiuge, A. Kurata, S. Kihara, I. Shimomura, and T. Funahashi Adiponectin protects against angiotensin II-induced cardiac fibrosis through activation of PPAR-alpha Arterioscler. Thromb. Vasc. Biol. 28 2008 863 870
27. M.O. Gray, C.S. Long, J.E. Kalinyak, H.T. Li, and J.S. Karliner Angiotensin II stimulates cardiac myocyte hypertrophy via paracrine release of TGF-beta 1 and endothelin-1 from fibroblasts Cardiovasc. Res. 40 1998 352 363
28. J. Gaedeke, H. Peters, N.A. Noble, and W.A. Border Angiotensin II, TGF-beta and renal fibrosis Contrib. Nephrol. 2001 153 160
29. H. Noh, H. Ha, M.R. Yu, Y.O. Kim, J.H. Kim, and H.B. Lee Angiotensin II mediates high glucose-induced TGF-beta1 and fibronectin upregulation in HPMC through reactive oxygen species Perit. Dial. Int. 25 2005 38 47
30. Y. Shibasaki, T. Nishiue, H. Masaki, K. Tamura, N. Matsumoto, Y. Mori, M. Nishikawa, H. Matsubara, and T. Iwasaka Impact of the angiotensin II receptor antagonist, losartan, on myocardial fibrosis in patients with end-stage renal disease: assessment by ultrasonic integrated backscatter and biochemical markers Hypertens. Res. 28 2005 787 795
31. H. Tachikawa, M. Kodama, L. Hui, T. Yoshida, M. Hayashi, S. Abe, T. Kashimura, K. Kato, H. Hanawa, K. Watanabe, M. Nakazawa, and Y. Aizawa Angiotensin II type 1 receptor blocker, valsartan, prevented cardiac fibrosis in rat cardiomyopathy after autoimmune myocarditis J. Cardiovasc. Pharmacol. 41 Suppl. 1 2003 S105 S110
32. W. Duan, X. Shen, J. Lei, Q. Xu, Y. Yu, R. Li, E. Wu, and Q. Ma Hyperglycemia, a neglected factor during cancer progression Biomed. Res. Int. 2014 2014 461917
33. N. Suskin, R.S. McKelvie, R.J. Burns, R. Latini, D. Pericak, J. Probstfield, J.L. Rouleau, C. Sigouin, C.B. Solymoss, R. Tsuyuki, M. White, and S. Yusuf Glucose and insulin abnormalities relate to functional capacity in patients with congestive heart failure Eur. Heart J. 21 2000 1368 1375
34. M. Aragno, R. Mastrocola, G. Alloatti, I. Vercellinatto, P. Bardini, S. Geuna, M.G. Catalano, O. Danni, and G. Boccuzzi Oxidative stress triggers cardiac fibrosis in the heart of diabetic rats Endocrinology 149 2008 380 388
35. B. Dai, M. Cui, M. Zhu, W.L. Su, M.C. Qiu, and H. Zhang STAT1/3 and ERK1/2 synergistically regulate cardiac fibrosis induced by high glucose Cell. Physiol. Biochem. 32 2013 960 971
36. R. Tang, Q. Li, L. Lv, H. Dai, M. Zheng, K. Ma, and B. Liu Angiotensin II mediates the high-glucose-induced endothelial-to-mesenchymal transition in human aortic endothelial cells Cardiovasc. Diabetol. 9 2010 31
37. J. Li, X. Qu, S.D. Ricardo, J.F. Bertram, and D.J. Nikolic-Paterson Resveratrol inhibits renal fibrosis in the obstructed kidney: potential role in deacetylation of Smad3 Am. J. Pathol. 177 2010 1065 1071
38. N. Hamdaoui, M. Baudoin-Legros, M. Kelly, A. Aissat, S. Moriceau, D.L. Vieu, J. Colas, J. Fritsch, A. Edelman, and G. Planelles Resveratrol rescues cAMP-dependent anionic transport in the cystic fibrosis pancreatic cell line CFPAC1 Br. J. Pharmacol. 163 2011 876 886
39. P.M. Di, M. Divi, A. Rodriguez-Vilarrupla, E. Rosado, J. Gracia-Sancho, M. Vilaseca, J. Bosch, and J.C. Garcia-Pagan Resveratrol improves intrahepatic endothelial dysfunction and reduces hepatic fibrosis and portal pressure in cirrhotic rats J. Hepatol. 58 2013 904 910